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More than half of the nascent B cells in humans
initially express autoreactive antibodies. How-
ever,most of these autoantibodies are removed
from the repertoire at two checkpoints before
maturation into naive B cells. A third checkpoint
excludes remaining autoantibodies from the
antigen-experienced IgM+ memory B cell pool.
Nevertheless, low-affinity self-reactive anti-
bodies are frequently found in the serum of
normal humans. To determine the source of
these antibodies, we cloned and expressed an-
tibodies from circulating human IgG+memory B
cells. Surprisingly, we found that self-reactive
antibodies including anti-nuclear antibodies
were frequently expressed by IgG+ memory B
cells in healthy donors. Most of these anti-
bodies were created de novo by somatic hyper-
mutation during the transition between mature
naive and IgG+ memory B cells. We conclude
that deregulation of self-reactive IgG+ memory
B cells may be associated with autoimmunity.
INTRODUCTION
Random immunoglobulin (Ig) gene recombination fre-
quently produces self-reactive antibodies: as many as
75% of newly generated B cells in the bone marrow
show reactivity to human epithelial larynx carcinoma
HEp-2 cells in clinical anti-nuclear antibody (ANA) ELISA
or immunofluorescence (Wardemann et al., 2003). A sub-
stantial fraction of these autoantibodies are polyreactive
andmany recognize nuclear self-antigens. However, poly-
reactive antibodies and true ANAs are tightly regulated by
central and peripheral self-tolerance mechanisms. Thus,
few self-reactive naive B cells persist, and these express
polyreactive antibodies or HEp-2 reactive antibodies with
only low amounts of reactivity for cytoplasmic antigens
but not nuclear antigens (Wardemann et al., 2003).
Mature naive B cells responding to antigen differentiate
into antibody-secreting plasma cells and memory B cellsIm(McHeyzer-Williams and McHeyzer-Williams, 2005;
Meffre et al., 2000; Radbruch et al., 2006; Rajewsky,
1996; Shapiro-Shelef and Calame, 2005). In humans,
two types of memory B cells have been described: IgM+
memory B cells and class-switched memory B cells
(Agematsu et al., 1997; Klein et al., 1998; Tangye et al.,
1998). Little is known about the origin of IgM+ memory B
cells, but by analogy to the mouse, it has been proposed
that these cells are products of T cell-independent im-
mune responses (Weller et al., 2001, 2004). We have
shown that the transition from naive B cells into circulating
IgM+memory B cells is accompanied by efficient counter-
selection against self-reactive naive B cells before the
onset of somatic hypermutation and that the few self-
reactive IgM+ memory B cells present in the circulation
of healthy humans gain self-reactivity as a result of
somatic hypermutation (Tsuiji et al., 2006).
In contrast, development of most class-switched mem-
ory B cells depends on the germinal center reaction and T
cell help. Ig class switching is accompanied by extensive
Ig gene somatic hypermutation that could change anti-
body affinity or create self-reactive antibodies (Ray
et al., 1996; Shlomchik et al., 1990; van Es et al., 1991).
To examine the establishment of self-tolerance in class-
switched IgG+ memory B cells, we cloned, expressed,
and measured the reactivity of 141 antibodies from human
IgG+memory B cells isolated fromperipheral blood of three
healthy donors. Surprisingly, we found that self-reactive an-
tibodies including true ANAs and polyreactive antibodies
were substantially enriched in circulating IgG+ memory B
cells relative to naive B cells and IgM+ memory B cells.
Our finding that a large number of circulating IgG+mem-
ory B cells normally express autoantibodies suggests that
abnormalities in the regulation or activation of peripheral
self-reactive IgG+ memory B cells may contribute to the
development of autoimmunity in susceptible individuals.
RESULTS
Features of IgG+ Memory B Cell Antibodies
To characterize the antibody gene repertoire of IgG+ mem-
ory B cells, we isolated single IgG+CD27+CD19+CD10
peripheral blood cells from three healthy donors and cloned
their IgH and IgL chains (Figure 1; see Figure S1 and Tablesmunity 26, 205–213, February 2007 ª2007 Elsevier Inc. 205
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Human IgG+ Memory B Cell AntibodiesFigure 1. IgH and IgL Chain Gene Features from IgG Memory B Cell Antibodies
(A) IgG subclass distribution in single IgG+CD27+ memory B cells from three healthy donors.
(B) The number of mutations in VH, Vk, and Vl genes in antibodies from IgG+ memory B cells.
(C) The frequency of mutations in VH, Vk, and Vl genes in antibodies from IgG+ memory B cells calculated from the number of replacement (R; black
bar) and silent (S; white bar) nucleotide exchanges per base pair in FWRs and CDRs. The R/S ratio for each region is indicated.
(D) IgH V and J gene repertoire and IgH CDR3 positive charges and length in amino acids (aa) of antibodies from IgG+ memory B cells compared to
mature naive B cells. Pie charts depict VH and JH family usage and the proportion of IgH CDR3s with 0, 1, 2, orR3 positive charges. p values for VH
and JH usage and IgH CDR3-positive charges were calculated by 23 5 Fisher exact test. Bar graphs show frequencies of IgH CDR3s with 9 aa (white
bars), 10–14 aa (light gray bars), 15–19 aa (dark gray bars), andR20 aa (black bars). p values for IgH CDR3 aa length were calculated by two-tailed
nonparametric t test. The absolute number of sequences analyzed is indicated in the center of each pie chart. Values for mature naive B cells in this
and other figures were published previously and are shown here for comparison (Tsuiji et al., 2006; Wardemann et al., 2003).S1–S3 in theSupplemental Data available online; Agematsu
et al., 1997; Klein et al., 1998; Plebani et al., 1989; Tangye
et al., 1998). B cells from all three donors showed an Ig sub-206 Immunity 26, 205–213, February 2007 ª2007 Elsevier Inc.class distribution reflecting that of human serum IgG anti-
bodies with IgG1>IgG2>IgG3>IgG4 (Figure 1A; on average
63.4% IgG1, 25.5% IgG2, 8.9% IgG3, and 2.2% IgG4) and
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Human IgG+ Memory B Cell AntibodiesFigure 2. Self-Reactive Antibodies Are Enriched in the IgG+ Memory B Cell Pool
(A) IgG+memory B cell antibodies from healthy donors were tested for self-reactivity by HEp-2 cell lysate ELISA and IFA. Horizontal line shows cut-off
OD405 for positive reactivity determined by comparison to low positive control serum (red line). Typical HEp-2 cell IFA staining patterns of antibodies
cloned from IgG+ memory B cells are shown. Data shown are representative for at least two independent experiments. p values were calculated by
2 3 2 Fisher exact test.
(B) Pie charts summarizing the frequency of HEp-2 self-reactive IgG+memory B cell antibodies with nuclear (black), nuclear plus cytoplasmic (dark gray),
and cytoplasmic (light gray) IFA staining patterns, and the frequency of nonreactive antibodies (white) in comparison tomature naive and IgM+memory B
cell clones (Tsuiji et al., 2006;Wardemann et al., 2003). The number of tested antibodies is indicated in eachpie chart center. p values are in comparison to
mature naive B cells and IgM+ memory B cells (Tsuiji et al., 2006; Wardemann et al., 2003) and were calculated by 23 5 Fisher exact test.
(C) SerumIgGANAamountsof threehealthydonorsandonepatientwith systemic lupuserythematosus (SLE101;Yurasovetal., 2005)weredeterminedby
HEp-2-ANA-ELISA. Themanufacturer’s instructionswere followed to calculate relative units basedon internal positive and negative control sera.Horizon-
tal lines show positive, low positive, or negative cut-off titres as indicated.were somatically mutated with an average 18.0 ± 8.1, 9.7 ±
5.4, and 7.7 ± 4.0 mutations for IgH, Igk, and Igl V genes,
respectively (Figures 1B and 1C). There were no major dif-
ferences in IgV gene-mutation frequencies among IgG iso-
types (data not shown), and as expected, replacement mu-
tations were more frequent than silent mutations in heavy
and light chain V gene complementary-determining regions
(CDRs) compared to framework regions (FWRs), suggest-
ing antigen-mediated selection (Figure 1C). Overall, IgH,
Igk, and Igl light chain gene usage was similar between
IgG memory and IgM mature naive B cell antibodies, but
antibodieswith positively charged IgHCDR3 regions, a fea-
ture associated with self-reactivity, were enriched in IgG+
memory B cells (Figure 1D; p = 0.014; Jang et al., 1998;
Radic et al., 1993).
IgG+ Memory B Cells Frequently Express
Self-Reactive Antibodies
Human epithelial cell line, HEp-2 enzyme-linked immuno-
sorbent assay (ELISA), and indirect immunoflourescenceIassay (IFA) are used as diagnostic tests to detect self-
reactive antibodies in the serum of patients with auto-
immune diseases (Egner, 2000). We used both assays to
determine the frequency of self-reactive IgG memory B
cell antibodies and to define their subcellular staining pat-
terns (Figure 2 and Tables S1–S3). Nearly half of the 141
IgG memory B cell antibodies from three healthy donors
showed low amounts of HEp-2 reactivity (Figure 2A;
46.8%). Although there was individual variation (Figure 2A;
62.8% for VB, 46.3% for PN, and 31.8% for HW), the fre-
quency of HEp-2 self-reactive antibodies was higher in
IgG+ memory B cells in all donors compared to antibodies
from mature naive B cells and IgM+ memory B cells (Fig-
ure 2B; Tsuiji et al., 2006; Wardemann et al., 2003).
Somemature naive B cells do express HEp-2-reactive an-
tibodies, but these are rarely true ANAs and usually recog-
nize cytoplasmic antigens (Wardemann et al., 2003). In
contrast, a major fraction of the self-reactive antibodies
produced by IgG+ memory B cells from all three donors
showed true ANA staining patterns by IFA includingmmunity 26, 205–213, February 2007 ª2007 Elsevier Inc. 207
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Human IgG+ Memory B Cell AntibodiesFigure 3. Polyreactive Antibodies Contribute to the IgG+ Memory B Cell Compartment
IgG+ memory B cell antibodies from healthy donors were tested for polyreactivity by ELISA with dsDNA, ssDNA, LPS, and insulin. Dotted lines rep-
resent the high-positive control antibody ED38 (Meffre et al., 2004). Horizontal lines show cut-off OD405 for positive reactivity as determined by com-
parison to the negative control antibody mGO53 (green line) and low-positive control eiJB40 (red line; Wardemann et al., 2003). Data shown are rep-
resentative for at least three independent experiments. Pie charts show the frequency of polyreactive clones from IgG+ memory B cells from all three
donors compared to mature naive B cell and IgM+ memory B cell antibodies (Tsuiji et al., 2006; Wardemann et al., 2003). The number of tested an-
tibodies is indicated in the center. p values are in comparison to mature naive B cells and IgM+ memory B cells (Tsuiji et al., 2006; Wardemann et al.,
2003) and were calculated by 2 3 2 Fisher exact test.nuclear and nucleolar patterns typically associated with
autoimmune diseases such as systemic lupus erythema-
tosus (SLE), rheumatoid arthritis, or scleroderma (Fig-
ure 2). It is important to note that all three donors studied
showed normal serum ANA IgG titres compared to pa-
tients with SLE (Figure 2C). We conclude that in healthy
humans, self-reactive antibodies including ANAs are
more abundant in the IgG+ memory B cells than in mature
naive B cells and IgM+ memory B cells.
Polyreactive Antibodies Expressed by IgG+
Memory B Cells
To screen for polyreactive antibodies, we tested the 141
IgGmemory B cell antibodies for reactivity against a panel
of defined antigens including double-stranded and single-
stranded DNA (dsDNA and ssDNA), insulin, and lipopoly-
saccharide (LPS; Figure 3). We found that on average,
22.7% of the antibodies were polyreactive (Figure 3;208 Immunity 26, 205–213, February 2007 ª2007 Elsevier Inc.23.3% for VB, 22.2% for PN, and 22.7% for HW), and
these antibodies recognized several strains of bacteria
and bacterial antigens (Figure S2 and Tables S1–S3). In
addition, a substantial fraction of IgG memory B cell anti-
bodies reacted with several strains of bacteria but not
with self-antigens (20.9% for VB, 20.4% for PN, and
15.9% for HW; Figure S2 and Tables S1–S3), and 1/141
antibodies showed high specificity with Staphylococcus
aureus but not with any of the other antigens tested (HW
224; Figure S2 and Table S3). We conclude that the fre-
quency of polyreactive antibodies is significantly higher
in the IgG+ memory B cell compartment than in mature
naive B cells (22.7% versus 6.2% in mature naive; p <
0.0001; Figure 3; Wardemann et al., 2003) or IgM+ mem-
ory B cells (22.7% versus 1.0% in IgM+ memory; p <
0.0001; Figure 3; Tsuiji et al., 2006), with no substantial
differences between isotype subclasses (Tables S1–S3
and data not shown).
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Human IgG+ Memory B Cell AntibodiesFigure 4. Somatic Hypermutation Contributes to Self-Reactivity in IgG Memory B Cell Antibodies
(A) IgH and IgL chains from IgG+memory B cell antibodies were reverted into their germline counterparts by PCR. Recombinant polyreactive (top left)
and nonpolyreactive (bottom left) IgG+ memory B cell antibodies and their germline counterparts (right) were tested for polyreactivity by ELISA with
dsDNA, ssDNA, insulin, and LPS. Representative graphs with dsDNA as antigen are shown. Dotted lines represent the high-positive control antibody
ED38 (Meffre et al., 2004). Horizontal lines show cut-off OD405 for positive reactivity as determined by comparison to the previously published control
antibodies mGO53 (negative control: green line; Wardemann et al., 2003) and eiJB40 (low-positive control: red line; Wardemann et al., 2003). Data
shown are representative for ELISA reactivity measured with all four antigens. Reactivity with each antigen was tested in at least three independent
experiments.
(B) Typical HEp-2 cell IFA staining patterns of mutated IgG+ memory B cell antibodies (top) and their germline counterparts (bottom). Data shown are
representative of two independent experiments.Somatic Hypermutation Creates Polyreactivity
and Self-Reactivity
The increase in self-reactivity during the transition be-
tween mature naive and IgG+ memory B cells might be
due to a selective advantage for pre-existing self-reactive
cells, or selection for cells with self-reactive antibodies
produced by somatic hypermutation. To determine the
origin of the self-reactive antibodies, we reverted the
somatic mutations of 36 randomly chosen self- and poly-
reactive and nonreactive IgG memory B cell antibodies to
their unmutated germline forms by PCR (Table S4; Herve
et al., 2005; Tsuiji et al., 2006) and tested the recombinant
antibodies for polyreactivity with dsDNA, ssDNA, insulin,
and LPS (Figure 4 and Table S4 and data not shown).
Out of these 36 antibodies, 12 were initially polyreactiveIm(Figure 4A, top left). Of these, 3 (25%) still exhibited poly-
reactivity in the corresponding germline form, while the
other 9 (75%) were completely negative (Figure 4A, top
right). Of the remaining 24 antibodies that were not poly-
reactive in their mutated form (Figure 4A, bottom left),
the vastmajority (91.6%; 22/24) were also not polyreactive
in the absence of mutations (Figure 4A, bottom right). We
found only two antibodies out of the initial 36 that showed
polyreactivity in the germline but not in the mutated form
(Figure 4A, bottom right). Similar results were obtained
when HEp-2 cell reactivity was analyzed by IFA and ELISA
(Figures 4B; Figure S3 and Table S4 and data not shown).
We conclude that most self-reactive and polyreactive IgG
antibodies originate from precursors that acquired reac-
tivity by somatic hypermutation.munity 26, 205–213, February 2007 ª2007 Elsevier Inc. 209
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Most polyreactivity in human serum has been attributed to
IgM and not IgG (Coutinho et al., 1995; Guilbert et al.,
1982; Seigneurin et al., 1988). However, secreted IgM is
a pentamer, which has greater avidity thanmonomeric an-
tibodies such as IgG. To determine the role of avidity in
polyreactivity, we reduced and purifiedmonomeric human
IgM from serum of pooled donors and from two of our in-
dividual donors (Figure 5; Figure S4). When tested at equal
molar ratios in polyreactivity ELISAs with dsDNA, ssDNA,
insulin, and LPS, monomeric IgMs were less reactive than
purified serum IgG antibodies (Figure 5 and data not
shown). In contrast, the pentameric IgM antibodies were
more reactive than corresponding IgGs (Figure 5 and
data not shown). Thus, the increased avidity of multimeric
IgM is essential for their higher polyreactivity. We con-
clude that in humans, monomeric IgMs such as those
found in the B cell antigen receptor expressed on naive
and IgM+ memory B cells are less polyreactive than the
corresponding IgGs found on IgG+ memory B cells.
DISCUSSION
Isolated VH genes cloned from unseparated peripheral
human B cells show autoreactivity (Lecerf et al., 1998)
when expressed in bacteria. However, the reactivity of
the intact antibodies from which the VH genes were
cloned could not be determined because they were
expressed in the absence of light chains that play a very
important role in determining autoantibody reactivity
(Wardemann et al., 2004). Furthermore, the representation
of autoreactive B cells could not be assesed by such ap-
proaches because the amount of IgG mRNA produced
varies with the stage of B cell differentiation and because
Figure 5. Monomeric IgM from Human Serum Is Less
Self-Reactive than Serum IgG
Polymeric IgM from pooled human plasma of healthy donors (open
circles) and from serum of two healthy donors (PN, HW) was reduced
under mild conditions to its monomeric IgM subunits (filled circles).
Serum IgG antibodies from pooled human plasma of healthy donors
and from three healthy donors (PN, HW, VB) were purified with Pro-
tein-G beads (squares). Equal molar quantities of the antibodies
were tested by ELISA for reactivity against dsDNA, but data shown
are also representative for ELISA reactivity with ssDNA, insulin, and
LPS. Reactivity ELISAs with individual antigens were repeated at least
three times. Control antibodies were the highly polyreactive ED38
(dotted line; Meffre et al., 2004) and negative mGO53 (triangles;
Wardemann et al., 2003).210 Immunity 26, 205–213, February 2007 ª2007 Elsevier Inc.cloning from pools of cells would lead to overrepresenta-
tion by cells producing higher amounts of IgG mRNA.
To examine the development of B cell tolerance in hu-
mans, we cloned antibodies from developing, naive and
memory B cells and tested them for reactivity against
a panel of defined antigens and HEp-2 cells (Tsuiji et al.,
2006; Wardemann et al., 2003). We found that cells ex-
pressing self-reactive antibodies are efficiently excluded
from the naive and circulating IgM+ memory B cell pool
(Tsuiji et al., 2006; Wardemann et al., 2003). Surprisingly,
development of IgG memory involved selective enrich-
ment of B cells that produce antibodies that react with
self-antigens. Many of these self-reactive antibodies
were authentic ANAs as determined by IFA onHEp-2 cells.
Asmany as one out of three healthy humans showsANA
reactivity at a screening dilution of 1/40 in clinical ELISA
tests with HEp-2 cells (Egner, 2000). However, the cellular
origin of these ANAs has never been determined. Although
memory B cells do not produce high amounts of secreted
antibodies, they develop into plasma cells that do
(Bernasconi et al., 2002; Radbruch et al., 2006). Our
experiments suggest that the ultimate source of the high
amounts of self-reactive serum antibodies found in clinical
ELISA assays is the large number of memory B cells that
produce such antibodies.
What is the origin of the ANA expressing IgG+memory B
cells in normal humans? Only a few IgG memory B cell
antibodies were polyreactive in their germline form, re-
flecting the paucity of such cells in the naive B cell com-
partment (Wardemann et al., 2003). In addition, there
were no substantial differences in Ig gene usage between
mature naive B cells and IgG+ memory B cells including
VH4-34, which is thought to have intrinsic autoreactivity
(Cappione et al., 2005). Thus, there appears to be no initial
selection for or against low autoreactivity in B cells enter-
ing the germinal center (GC). Instead,most of the selection
occurs after somatic hypermutation either in the GC or af-
ter B cells emerge from the GC and enter the long-lived
IgG memory compartment. Irrespective of the compart-
ment in which the cells are selected or the mechanism,
it is likely that self-reactivity in the IgG+ memory B cell
compartment represents a by-product of affinity matura-
tion for binding to unknown foreign antigens (Casson
and Manser, 1995; Diamond and Scharff, 1984; Liu
et al., 1989; Pulendran et al., 1995, Han et al., 1995; Sho-
kat and Goodnow, 1995; Wellmann et al., 2005). Consis-
tent with this idea, polyreactive IgGs are highly mutated
with replacement/substitution ratios indicating antigen-
mediated selection (Berek et al., 1991; Weiss and Rajew-
sky, 1990). In addition, there are well-known examples of
highly specific human antibodies that are also polyreac-
tive, e.g., broadly neutralizing HIV antibodies (Haynes
et al., 2005; Muster et al., 1993; Zwick et al., 2001).
In mice, both low- and high-affinity B cells are initially
recruited to GCs, but competition ensures that only high-
affinity clones become memory cells (Paus et al., 2006;
Shih et al., 2002). Our experiments suggest that there is
also no initial selection against polyreactivity in seeding
GCs. Thus, patients with SLE and rheumatoid arthritis
Immunity
Human IgG+ Memory B Cell Antibodiesthat show abnormally high numbers of mature naive B
cells producing self-reactive and polyreactive antibodies
may also have larger numbers of such cells in GCs, but
whether this will impact on the nature of the memory
repertoire in these patients remains to be determined
(Samuels et al., 2005; Yurasov et al., 2005, 2006).
Finding large numbers of polyreactive B cells in the IgG
memory compartment was surprising becausemost poly-
reactivity in sera has been attributed to IgM (Coutinho
et al., 1995; Guilbert et al., 1982; Seigneurin et al., 1988).
However, any direct comparison of monomeric IgG and
pentameric IgM would naturally favor IgM because of
the greater avidity of the latter. Comparison of monomeric
serum IgM to IgG shows that it is the IgG fraction that con-
tains higher polyreactivity.
In mice, natural IgM antibodies with low self-reactivity
and polyreactivity are produced by B1 and marginal
zone B cells and they are protective early in immune re-
sponses to a variety of pathogens (Baumgarth et al.,
2000; Haas et al., 2005; Martin et al., 2001). The human
equivalents of the mouse B1 cells have not been defined,
and human marginal zone B cells differ from mouse mar-
ginal zone B cells in that they show signs of antigen-medi-
ated selection, display a memory B cell phenotype, and
circulate in the bloodstream (Weller et al., 2001, 2004).
Furthermore, the relative roles of IgM and IgG antibodies
in early protection against infection have not been deter-
mined in mouse or human. However, a role for IgG in early
protection in humans is suggested by increased suscepti-
bility to bacterial infection in patients unable to produce
IgG as a result of B cell-intrinsic hyper-IgM syndrome,
its reversal by passive transfer of pooled IgG, and by our
finding that IgGs are frequently reactive against a number
of different species of bacteria or bacterial antigens
(Alachkar et al., 2006; Quartier et al., 2004). In addition
to their role in immune protection, natural IgM antibodies
have also been implicated in prevention of autoimmunity
by binding and clearing of apoptotic cells (Kim et al.,
2002). A similar role for IgG in preventing autoimmunity
is suggested by the finding that patients with hyper-IgM
type 2 syndrome are also highly susceptible to autoimmu-
nity (Quartier et al., 2004). Despite the lower overall avidity
of IgGs, thesemoleculesmay be important in early protec-
tion against infection and in prevention of autoimmunity
because they can engage both the complement system
and Fc receptors (Carroll, 2004; Ravetch and Clynes,
1998). This feature enables a series of important protec-
tive effector functions not available to IgMs, which do
not bind to conventional Fc receptors.
In summary, our data demonstrate that a large number
of circulating IgG+ memory B cells normally produce
low-affinity nonpathogenic autoantibodies. How many of
these cells eventually develop into plasma cells and con-
tribute to steady-state antibody titers remains to be deter-
mined. Under normal conditions, autoreactive IgG+ mem-
ory B cells may be anergic. Alternatively, an additional and
yet-to-be-defined checkpoint may control the differentia-
tion of self-reactive IgG+ memory B cells into antibody-
secreting plasma cells (Han et al., 1995; Shokat andGoodnow, 1995; Pulendran et al., 1995; Klinman, 1996).
Nevertheless, abnormalities in checkpoint regulation or
activation of peripheral self-reactive IgG+ memory B cells
may contribute to the development of autoimmunity in
susceptible individuals (Bernasconi et al., 2002; Kaneko
et al., 2006; Mackay et al., 2006; Radbruch et al., 2006).
EXPERIMENTAL PROCEDURES
Single B Cell Sorting
All sampleswere obtained after signed informed consent in accordance
with IRB-reviewed protocols at the Rockefeller University. Control data
from mature naive B cells were previously published and are shown for
comparison. Single CD19+CD10CD27+IgG+ B cells were isolated as
described (Wardemann et al., 2003) after staining with anti-CD19-
APC, anti-CD10-PE, anti-CD27-FITC, anti-IgG-Biotin (BD Biosciences
Pharmigen), and Streptavidin-PECy7 (Caltag Laboratories).
PCR Amplification and Expression Vector Cloning
Single-cell cDNA synthesis was performed as described with Super-
script III at 50C (Wardemann et al., 2003). Igg, Igk, and Igl chain
genes were amplified in two rounds of nested PCR (T.T. and H.W.,
unpublished data; Tsuiji et al., 2006; Wardemann et al., 2003; Yurasov
et al., 2005, 2006). All PCR products were sequenced and analyzed for
Ig gene usage and CDR3 analysis, number of V gene mutations (Ig-
Blast; Tables S1–S3), and IgG isotype subclass (http://imgt.cines.fr).
Second PCR products for Igl genes contained restriction sites allow-
ing direct cloning into expression vectors. For Igg and Igk genes,
restriction sites for expression vector cloning were introduced after
sequencing by gene-specific primers and first PCR products as
template. All IgH and IgL chain genes were sequenced after cloning
to confirm entity with the original PCR products.
Antibody Production, ELISA, and Indirect
Immunofluorescence Assay
Antibodies were expressed and tested for polyreactivity with ds/
ssDNA, insulin, and LPS and for self-reactivity with HEp-2 cells by
ELISA and IFA as described (Wardemann et al., 2003). ELISA against
bacteria was described previously (Tsuiji et al., 2006). Threshold values
for reactivity are indicated in the graphs and were set in all assays with
our previously published control antibodies mGO53 (negative), eiJB40
(low positive), and ED38 (high positive) for polyreactivity ELISAs and
additional positive and negative control sera for HEp-2 reactivity
(Meffre et al., 2004; Wardemann et al., 2003). Data shown are repre-
sentative for at least two independent experiments.
Reversion of Hypermutated Sequences to Germline
Antibodies for reversion experiments were chosen randomly and are
listed in Table S4. Mutated IgH and IgL chain genes were reverted to
their germline sequence by two separate PCR reactions for the V
gene and the (D)J gene followed by a third overlap PCR to fuse the
two PCR products as described (Herve et al., 2005; Tsuiji et al.,
2006). All reverted IgH and IgL chain PCR products were sequenced
before and after cloning into the corresponding expression vectors
to confirm lack of mutations. Recombinant mutated and unmutated
antibodies were expressed and tested for polyreactivity and self-
reactivity in comparison as described above.
Statistics
p values for Ig gene repertoire analyses, analysis of positive charges in
IgH CDR3, and antibody reactivity were calculated by 2 3 2 or 2 3 5
Fisher Exact test or chi-square test. p values for IgH CDR3 length
were calculated by Student’s t test.
Serum IgM and IgG Purification and Reduction of IgM
IgM was purified from serum of three healthy donors as described
(Cambier and Butler, 1974). In brief, 20 ml of clarified whole serumImmunity 26, 205–213, February 2007 ª2007 Elsevier Inc. 211
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24 hr at 4C. Precipitates were dissolved in 4 ml 0.01 M acetate buffer
(pH 5.4) containing 0.15MNaCl. 0.1M ZnSO4was added drop-wise to
a final concentration of 10 mM. The preparations were stirred at 25C
for 2 hr prior to centrifugation at 3000 rpm for 15 min. Supernatants
were subjected to a Superdex200 column (GE Healthcare) equilibrated
with 0.1 M Tris-HCl buffer (pH 8.6) containing 0.1 M NaCl, and eluted
fractions were collected. IgG was purified from human serum of the
same three donors with Protein G beads (GE Healthcare) according
to the manufacturer’s instructions.
To obtain IgM subunits, IgMwas reduced in 0.5M Tris buffer (pH 8.6)
containing 10mMcysteine for 2–4 hr at room temperature. The optimal
incubation conditions were determined empirically for each IgM
preparation. The reaction was stopped with 10% molar excess of io-
doacteamide and applied to a Superdex200 column (GE Healthcare)
equilibrated with sodium borate buffer (pH 8.6). Size and purity of
the preparations was monitored by nonreducing SDS-PAGE (see
Figure S5). Monomeric IgM concentration was determined by serial di-
lution on SDS-PAGE with total human IgG (Sigma) standards. Equal
molar amounts of IgM (180 kDa) and IgG (156 kDa) were used in
indirect ELISAs with dsDNA, ssDNA, insulin, and LPS as antigens as
described above (Wardemann et al., 2003). Reactive antibodies were
detected with anti-human IgM plus IgG HRP antibody (Jackson Immu-
noResearch) and confirmed in independent experiments with either
anti-human kappa-HRP or anti-human lambda-HRP (Biosource).
Supplemental Data
Supplemental Data include four figures and four tables and can
be found with this article online at http://www.immunity.com/cgi/
content/full/26/2/205/DC1/.
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